Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Danielle S. Cha, Xinyi Luo, Juhie Ahmed, Larissa Becirovic, Rebekah H. Cha & Roger S. McIntyre. (2019) Brexpiprazole as an augmentation agent to antidepressants in treatment resistant major depressive disorder. Expert Review of Neurotherapeutics 19:9, pages 777-783.
Read now
Read now
Awais Aftab & Keming Gao. (2017) The preclinical discovery and development of brexpiprazole for the treatment of major depressive disorder. Expert Opinion on Drug Discovery 12:10, pages 1067-1081.
Read now
Read now
Kinjal Patel, Petal S. Abdool, Tarek K. Rajji & Benoit H. Mulsant. (2017) Pharmacotherapy of major depression in late life: what is the role of new agents?. Expert Opinion on Pharmacotherapy 18:6, pages 599-609.
Read now
Read now
Articles from other publishers (12)
Liyuan Chen, Tianyuan Ye, Xiaolong Wang, Lu Han, Tongxing Wang, Dongmei Qi & Xiaorui Cheng. (2023) The Mechanisms Underlying the Pharmacological Effects of GuiPi
Decoction on Major Depressive Disorder based on Network Pharmacology
and Molecular Docking. Combinatorial Chemistry & High Throughput Screening 26:9, pages 1701-1728.
Crossref
Crossref
Silviya Ralovska, Ivan Koychev, Petar Marinov, Toshi A Furukawa, Benoit Mulsant & Andrea Cipriani. (2023) Brexpiprazole versus placebo or other antidepressive agents for treating depression. Cochrane Database of Systematic Reviews 2023:7.
Crossref
Crossref
Reza Emadi, Abbas Bahrami Nekoo, Fatemeh Molaverdi, Zahra Khorsandi, Reza Sheibani & Hojjat Sadeghi-Aliabadi. (2023) Applications of palladium-catalyzed C–N cross-coupling reactions in pharmaceutical compounds. RSC Advances 13:27, pages 18715-18733.
Crossref
Crossref
Bhoopendra Singh Kushwah, Saranjit Singh, Mohit M. Thummar, Ankit Balhara & Gananadhamu Samanthula. (2022) Characterization of potential degradation products of brexpiprazole by liquid chromatography/quadrupole–time‐of‐flight mass spectrometry and nuclear magnetic resonance, and prediction of their physicochemical properties by ADMET Predictor™. Rapid Communications in Mass Spectrometry 37:1.
Crossref
Crossref
Joanne S Carpenter, Natalia Zmicerevska, Jacob J Crouse, Alissa Nichles, Alexandra Garland, Yun Ju Christine Song, Chloe Wilson, Cathrin Rohleder, Catherine McHugh, F. Markus Leweke, Dagmar Koethe, Elizabeth M Scott & Ian B Hickie. (2022) Effects of adjunctive brexpiprazole on sleep-wake and circadian parameters in youth with depressive disorders: study protocol for a clinical trial. BMJ Open 12:9, pages e056298.
Crossref
Crossref
Stefania Chiappini, Alessio Mosca, Giovanni Martinotti, Francesco Di Carlo, Andrea Miuli, Luigi Dattoli, Mauro Pettorruso & Massimo Di Giannantonio. (2022) Brexpiprazole as a new approach of treatment in somatization disorder. Emerging Trends in Drugs, Addictions, and Health 2, pages 100031.
Crossref
Crossref
Shu-Yue Qu, Xiao-Yue Li, Xia Heng, Yi-Yu Qi, Ping-Yuan Ge, Sai-jia Ni, Zeng-Ying Yao, Rui Guo, Nian-Yun Yang, Yi Cao, Qi-Chun Zhang & Hua-Xu Zhu. (2021) Analysis of Antidepressant Activity of Huang-Lian Jie-Du Decoction Through Network Pharmacology and Metabolomics. Frontiers in Pharmacology 12.
Crossref
Crossref
Jayachandra Rayadurgam, Sravani Sana, M. Sasikumar & Qiong Gu. (2021) Palladium catalyzed C–C and C–N bond forming reactions: an update on the synthesis of pharmaceuticals from 2015–2020. Organic Chemistry Frontiers 8:2, pages 384-414.
Crossref
Crossref
Taro Kishi, Kenji Sakuma, Ikuo Nomura, Yuki Matsuda, Kazuo Mishima & Nakao Iwata. (2019) Brexpiprazole as Adjunctive Treatment for Major Depressive Disorder Following Treatment Failure With at Least One Antidepressant in the Current Episode: a Systematic Review and Meta-Analysis. International Journal of Neuropsychopharmacology 22:11, pages 698-709.
Crossref
Crossref
Aldarmaa Jalsrai, Avijit Biswas, Nikolai I. Suslov & Joseph V. Martin. (2019) Neuropsychopharmacological profile of Astragalus membranaceous var. mongholicus. Journal of Traditional Chinese Medical Sciences 6:3, pages 254-262.
Crossref
Crossref
John L. Beyer & Kim G. Johnson. (2018) Advances in Pharmacotherapy of Late-Life Depression. Current Psychiatry Reports 20:5.
Crossref
Crossref
Min Ma, Qian Ren, Yuko Fujita, Chun Yang, Chao Dong, Yuta Ohgi, Takashi Futamura & Kenji Hashimoto. (2017) Alterations in amino acid levels in mouse brain regions after adjunctive treatment of brexpiprazole with fluoxetine: comparison with (R)-ketamine. Psychopharmacology 234:21, pages 3165-3173.
Crossref
Crossref